Page last updated: 2024-09-05

ramelteon and Chronic Illness

ramelteon has been researched along with Chronic Illness in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adefuye, A; Budur, K; Calabrese, JR; Dong, X; Hanson, E; Macek, TA; Mahableshwarkar, AR; Sachs, GS	1
Mini, L; Wang-Weigand, S; Zhang, J	1
Richardson, GS; Wang-Weigand, S; Zammit, G; Zhang, J	1
Hirai, K; Kato, K; Miyamoto, M; Nishikawa, H; Nishiyama, K; Yukuhiro, N	1
Erman, M; Sainati, S; Seiden, D; Zammit, G; Zhang, J	1
Roth, T; Sainati, S; Seiden, D; Wang-Weigand, S; Zee, P; Zhang, J	1
Erman, M; Roth, T; Sainati, S; Wang-Weigand, S; Zammit, G; Zhang, J	1
Mini, LJ; Wang-Weigand, S; Zhang, J	1

Reviews

1 review(s) available for ramelteon and Chronic Illness

Article	Year
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:1 Topics: Animals; Chronic Disease; Cyclic AMP; Drug Evaluation, Preclinical; Humans; Indenes; Randomized Controlled Trials as Topic; Receptors, Melatonin; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance-Related Disorders; Suprachiasmatic Nucleus	2010

Article

Year

[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:1

Topics: Animals; Chronic Disease; Cyclic AMP; Drug Evaluation, Preclinical; Humans; Indenes; Randomized Controlled Trials as Topic; Receptors, Melatonin; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance-Related Disorders; Suprachiasmatic Nucleus

2010

Trials

6 trial(s) available for ramelteon and Chronic Illness

Article	Year
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. Journal of affective disorders, 2017, 10-15, Volume: 221 Topics: Administration, Sublingual; Adult; Affect; Bipolar Disorder; Chronic Disease; Combined Modality Therapy; Double-Blind Method; Female; Humans; Indenes; Maintenance Chemotherapy; Male; Middle Aged; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Research Design; Treatment Outcome	2017
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4 Topics: Adolescent; Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Indenes; Male; Melatonin; Middle Aged; Severity of Illness Index; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Testosterone; Thyroxine; Young Adult	2009
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep medicine, 2006, Volume: 7, Issue:1 Topics: Adolescent; Adult; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indenes; Male; Melatonin; Middle Aged; Polysomnography; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome	2006
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep medicine, 2006, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors	2006
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2007, Aug-15, Volume: 3, Issue:5 Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Middle Aged; Polysomnography; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome	2007
Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. The American journal of geriatric pharmacotherapy, 2007, Volume: 5, Issue:3 Topics: Aged; Chronic Disease; Dizziness; Double-Blind Method; Dysgeusia; Female; Headache; Humans; Hypnotics and Sedatives; Indenes; Male; Muscular Diseases; Pain; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep Initiation and Maintenance Disorders; Time Factors	2007

Other Studies

1 other study(ies) available for ramelteon and Chronic Illness

Article	Year
Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Clinical therapeutics, 2008, Volume: 30, Issue:7 Topics: Adult; Chronic Disease; Female; Humans; Indenes; Male; Randomized Controlled Trials as Topic; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors	2008

Article

Year

Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.

Clinical therapeutics, 2008, Volume: 30, Issue:7

Topics: Adult; Chronic Disease; Female; Humans; Indenes; Male; Randomized Controlled Trials as Topic; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors

2008